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Prospects for Clinical Research! 
G. Donald Whedon, MD' 
0 ne of the principal reasons I have been invited to speak 
here at Henry Ford Hospital is my very long friendship with 
Richmond Smith. Rich and I go back to the 1940s when we 
were research fellows (along with George Hamwi, Bill 
Thomas, and Anne Carter) in Ephraim Shorr's Endocrinol-
ogy Division of the New York Hospital-Cornell Medical 
Center. The quality and effectiveness of Dr. Smith's hard 
work in endocrinology and in internal medicine have been 
well known over the years far beyond Detroit. Through all 
the years that he has been here and I have been in 
Bethesda, the close friendship of our early fellowship days 
has persisted. There is something very special about early 
friends; these are not only the longest of friendships, but 
also the closest and best. 
1 hope it wil l interest staff members of one of the greatest 
clinical care establishments in the world to hear from us in 
the National Institutes of Health (NIH), the institution 
which supports with federal funds two thirds of medical 
research in the U.S., some perspectives on support of 
medical research and education. The association of medi-
cal research, education, and clinical care is probably far 
closerthan any of us realize, but the quality of clinical care, 
and probably its quanitity, are inevitably dependent upon 
the quality and quantity of the development of new bio-
medical knowledge, the training of young physicians, and 
the continual updating of their skills. From all that I have 
seen and heard, particularly over the past few years, Henry 
Ford Hospital fully understands and lives by the close 
interrelat ionship of these three cardinal elements of 
medicine. 
In addressing the question, "What is the future of support 
for medical research and education?" we recently exam-
ined all the NIH data we could on research grants and 
training. The history of research grant funding from 1950, 
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the year by which a considerable number of Institutes had 
been founded and extramural programs had begun, 
showed slow early beginnings and then a rapid growth 
during the late 1950s and early 1960s. NIH support of 
research increased steadily until the final years of the 
Johnson Administration; then there was level funding over 
the next six years and even an impoundment of funds in 
1973; then "escape" during the Ford Administration. It 
seems particularly appropriate for me to mention here one 
ofthe very beneficial influences of the Ford Administration. 
The "escape" varied from Institute to Institute but was 
greatest for the National Cancer Institute (NCI) and the 
National Heart, Lung, and Blood Institute (NHLBI), partic-
ularly from 1973-76. The budgetof the National Institute of 
Arthritis, Metabolism, and Digestive Diseases (NIAMDD) 
began to grow again during 1976-79, due mainly to phe-
nomenal public and Congressional interest in diabetes. 
Increased funding in recent years, of course, has meant 
recovery, but a better physical sign for diagnosis of the state 
of health of medical research has been the increase in 
numbers of research grant app/ications, particularly during 
the past two years, an indication of the vitality of interest in 
research among investigators in universities and medical 
centers. 
Despite this reasonably healthy state at present, as indi-
cated by funding and numbers of applications, leaders of 
medical societies have recently expressed considerable 
concern for the future of research and particularly of cl ini-
cal research. The pertinent NIH data show that although 
the actual number of MD investigators has held level over 
the past half dozen years, the proportion of MDs among 
principal investigators on research grants has declined, due 
to the considerable increase in the number of PhDs as 
principal investigators. We feel some reassurance from the 
fact that MDs are scoring as well as PhDs in reviews oftheir 
grant proposals and in the proportion of awards to the 
number of appl ications. The data reviewed, however, show 
disturbing portents for the future of training grants and 
fellowships. Since 1974, the number of MDs receiving 
research fellowships has steadily dropped. My concern for 
the future of clinical research is increased by the know-
ledge that this drop in MD fellowships and traineeships is 
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not due to a decrease in training funds, since fully one 
fourth of the available training and fellowship slots have 
not been filled. 
There are probably several reasons for declining interest in 
research on the part of medical students and residents. 
1) Predominant interest in delivery of medical care. 
2) An accompanying belief that society is more approv-
ing of the good physician than of the professor/ 
investigator. 
3) Uncertainty as to the continuity or long-term stability 
of support for research from the largest source of 
support, the federal government (which I believe is 
an exaggerated and unsound reason). 
4) Revision in medical school curricula so that exposure 
to laboratory techniques has been limited. 
5) Recent changes in specialty board requirements and 
increased interest in sub-specialty certification. After 
graduation a longer time is spent in clinical diagnos-
tic and care experience, and the opportunity to enter 
research is long delayed. Growing economic pres-
sures to go into practice are extremely difficult to 
resist. 
6) Economic pressure per se. 
The NIH has already begun to respond to this situation in 
several ways, particularly in the form of new or unusual 
means of support for those interested in research careers. 
These include so-called Young Investigator awards and, in 
NIAMDD, a Clinical Investigator award program for indi-
viduals with four to seven years' postdoctoral experience. 
In the field of diabetes we have just initiated a Special 
Emphasis Research Career Award (SERCA) and a New 
Investigator Research Award. Depending on our experi-
ence in diabetes, we probably could extend these two new 
research exposure and "training" activities to other pro-
gram areas. 
Among other actions which the NIH wi l l be taking, as of 
Ju l y l , 1980, is an increase in stipend levels for fellowships 
and traineeships. Now being issued are announcements of 
a revival of the "short-term training" program which wi l l 
take advantage of a revision the Congress made in the 
National Research Service Act in fall of 1978. The revision 
in this Act, which authorizes legislation for training, ex-
empts from payback training periods of from two weeks 
up to three months. "Non-payback training" of up to three 
months should provide an opportunity to begin to instill 
research principles into receptive students and might weigh 
positively in the balance of a career choice. The require-
ment for "specialized intensive training courses," we 
think, can be satisfied by having groups of trainees from a 
number of training programs in the same school attend a 
systematized series of seminars on research methodology, 
technology, biostatistics, etc. 
The resources of government support, however, can do 
only so much. There must be an intrinsic or endogenous re-
awakening of interest in research, starting at the medical 
student level in the medical schools. Equally important, the 
great hospitals have an important role to play. Not only do 
they provide the best care for patients but, like Henry Ford 
Hospital, they are the major educational institutions for 
postgraduate clinical training and experience, which takes 
place through the residency and young physician levels. 
Henry Ford Hospital is so renowned for quality of care that 
its contributions to the development o fa "better product" 
for the consumer patient are not fully appreciated, espe-
cially locally. For many, many years at a low and quiet 
level, the Edsel Ford Institute for Medical Research put out 
very sound research by men well known in their respective 
fields. For many years, the clinicians, superbly trained, 
were providing advances in clinical knowledge by their 
astute observational powers, which were then communi-
cated to the medical community at large through many 
publications in many journals. 
But now. Ford Hospital has just entered a new and poten-
tially very great phase. Through the support of the Ford 
Foundation, with the building of the Benson Ford Education 
and Research Center, and the commitment o f the admin-
istration, all led by Richmond Smith, you are now putting 
into action a superb demonstration ofthe interdependence 
and inseparability of new knowledge produced by re-
search, of medical education and clinical training, and of 
quality care of patients. In this remarkable new setting, the 
medical staff has the chance to lend a forceful hand to the 
renaissance of c l in ica l investigation we surely need 
nationally. 
I urge the medical staff here to have a stronger feeling of 
their role, oftheir special opportunity, and oftheir respon-
sibility, to do more in clinical research. Furthermore, renew 
your efforts to infuse residents and affiliated medical stu-
dents with a spirit of enjoyment, even excitement, in 
observing, in measuring, in planning clinical experiments, 
and in finding new facts and correlations that may give 
clues to practical, positive influences on disease, the treat-
ment of which is so much in the minds of medical students 
and residents today. 
This brief message, accenting the undergirding importance 
of research to clinical care, is not new to you, except 
perhaps as a call for help in bringing about a recovery of 
clinical investigation. You have heard this message from 
Richmond Smith over all the years of his service to this 
renowned institution. I simply urge you to hear him again, 
or hear him still, and to continue the fine performance you 
have made over the years under his leadership. 
I l l 
